Amedisys/ US0234361089 /
2024-11-08 9:59:58 PM | Chg. -0.08 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
96.72USD | -0.08% | 70,755 Turnover: 6.84 mill. |
-Bid Size: - | -Ask Size: - | 3.17 bill.USD | - | - |
Assets
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 156.7000 | 159 | 137.4550 | 42.6950 | 36.9990 | ||||||
Intangible Assets | 47.1000 | 36.7000 | 33.1930 | 44.0470 | 46.7550 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | - | 534.1840 | 509.8220 | 519.1190 | ||||||
Inventories | - | - | - | - | - | ||||||
Accounts Receivable | 169.2000 | 111.1000 | 99.3250 | 125.0100 | 166.0560 | ||||||
Cash and Cash Equivalents | 14.5000 | 17.3000 | 8.0320 | 27.5020 | 30.1970 | ||||||
Current Assets | 205.8000 | 205.3000 | 135.5580 | 175.2630 | 214.9100 | ||||||
Total Assets | 730.6000 | 726.4000 | 669.7420 | 685.0850 | 734.0290 |
Liabilities
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 29.2000 | 20.1000 | 16.0560 | 25.6820 | 30.3580 | ||||||
Long-term debt | 66.9000 | 33 | 104.3720 | 95 | 87.8090 | ||||||
Liabilities to Banks | 102.7000 | 46.9000 | 116.4000 | 100 | 93 | ||||||
Provisions | 5.6000 | - | 2.4000 | - | - | ||||||
Liabilities | 276.4000 | 353.9000 | 271.9800 | 274.6490 | 272.8870 | ||||||
Share Capital | .0300 | .0300 | .0350 | .0350 | .0350 | ||||||
Total Equity | 454.2000 | 372.5000 | 397.7620 | 410.4360 | 461.1420 | ||||||
Minority Interests | 1.9000 | .3000 | .5950 | .8680 | .9390 | ||||||
Total liabilities equity | 730.6000 | 726.4000 | 669.7420 | 685.0850 | 734.0290 |
Income Statement
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1,487.9000 | 1,249.3000 | 1,204.5540 | 1,280.5410 | 1,437.4540 | ||||||
Depreciation (total) | 39.9000 | 36.9000 | 28.3470 | 20.0360 | - | ||||||
Operating Result | -112.2000 | -155 | 24.0470 | -9.1660 | 57.3400 | ||||||
Interest Income | -12.1300 | -4.3500 | -8.1230 | -10.7120 | -5.0890 | ||||||
Income Before Taxes | -118.7000 | -153.5000 | 20.9760 | -.3080 | 61.5660 | ||||||
Income Taxes | -21.4000 | -58.8000 | -7.6710 | -2.0040 | -23.9350 | ||||||
Minority Interests Profit | 15 | 1.6000 | -.3130 | -.7090 | -.3700 | ||||||
Net Income | -83.6000 | -96.2000 | 12.7760 | -3.0210 | 37.2610 |
Per Share
Cash Flow
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 69.5000 | 102.3000 | -65.5340 | 107.7850 | 62.2590 | ||||||
Cash Flow from Investing Activities | -60 | -46.5000 | -14.3000 | -67.4210 | -52.0490 | ||||||
Cash Flow from Financing | -43 | -53 | 70.5630 | -20.8940 | -7.5150 | ||||||
Decrease / Increase in Cash | -33.5000 | 2.8000 | -9.2710 | 19.4700 | 2.6950 | ||||||
Employees | 15,200 | 14,300 | 13,200 | 16,100 | 16,000 |